¼¼°èÀÇ ÀǾàǰ ÷°¡Á¦ ½ÃÀå : Á¦Ç°º°, ±â´Éº°, Á¦Çüº°, ±â´É¼º ¿ëµµº°, Áö¿ªº° ¿¹Ãø(-2030³â)
Pharmaceutical Excipients Market by Product ((Organic, Inorganic)), Functionality, Formulation, Functionality Application - Global Forecast to 2030
»óǰÄÚµå : 1777131
¸®¼­Ä¡»ç : MarketsandMarkets
¹ßÇàÀÏ : 2025³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 633 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,950 £Ü 6,972,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,650 £Ü 9,366,000
PDF (5-user License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,150 £Ü 11,479,000
PDF (Corporate License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÀÌ¿ë Àοø¿¡ Á¦ÇÑÀº ¾øÀ¸³ª, ±¹³»¿¡ ÀÖ´Â »ç¾÷À常 ÇØ´çµÇ¸ç, ÇØ¿Ü ÁöÁ¡ µîÀº Æ÷ÇÔµÇÁö ¾Ê½À´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 10,000 £Ü 14,085,000
PDF (Global License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. (100% ÀÚȸ»ç´Â µ¿ÀÏ ±â¾÷À¸·Î °£Áֵ˴ϴÙ.) Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼¼°èÀÇ ÀǾàǰ ÷°¡Á¦ ½ÃÀå ±Ô¸ð´Â 2025³â 110¾ï 3,000¸¸ ´Þ·¯¿¡¼­ 2030³â¿¡´Â 148¾ï 6,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ¿¹Ãø ±â°£ Áß CAGRÀº 6.1%¸¦ ³ªÅ¸³¾ Àü¸ÁÀÔ´Ï´Ù.

Á¶»ç ¹üÀ§
Á¶»ç ´ë»ó ¿¬µµ 2023-2030³â
±âÁØ ¿¬µµ 2024³â
¿¹Ãø ±â°£ 2025-2030³â
°ËÅä ´ÜÀ§ ±Ý¾×(10¾ï ´Þ·¯)
ºÎ¹®º° Á¦Ç°º°, ±â´É¼ºº°, Á¦Çüº°, ±â´É¼º ¿ëµµº°, Áö¿ªº°
´ë»ó Áö¿ª ºÏ¹Ì, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

ÀǾàǰ ÷°¡Á¦ ½ÃÀåÀÇ È®ÀåÀº ÁÖ·Î ÀǾàǰ ¹× Á¦³×¸¯ ÀǾàǰ¿¡ ´ëÇÑ ¼ö¿äÀÇ ±ÞÁõ¿¡ ÀÇÇØ ÃËÁøµÇ¾úÀ¸¸ç, »õ·Î¿î ÷°¡Á¦ °³¹ßÀ» À§ÇÑ R&D ÅõÀÚ°¡ ÇâÈÄ ¸î ³â µ¿¾È ½ÃÀåÀ» Ȱ¼ºÈ­ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ, Á¦¾à ȸ»ç¿ÍÀÇ ÆÄÆ®³Ê½Ê ¹× Çù·Â, ±×¸®°í ȯÀÚ Á᫐ Á¦Çü¿¡ ´ëÇÑ °­Á¶°¡ Áõ°¡ÇÔ¿¡ µû¶ó À¯¸®ÇÑ ½ÃÀå ¼ºÀå ±âȸ°¡ Á¦°øµÉ °ÍÀÔ´Ï´Ù. ±×·¯³ª, ¾ö°ÝÇÑ ±ÔÁ¦¿Í ³ôÀº °³¹ß ºñ¿ëÀÌ ½ÃÀåÀ» Á¦ÇÑÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Pharmaceutical Excipients Market-IMG1

±â´Éº°·Î ºÐ·ùµÈ ÀǾàǰ ÷°¡Á¦ ½ÃÀå¿¡´Â °áÇÕÁ¦, ÇöŹÁ¦ ¹× Á¡µµÁ¦, ÃæÀüÁ¦ ¹× Èñ¼®Á¦, Çâ·á ¹× °¨¹Ì·á, Âø»öÁ¦, ÄÚÆÃÁ¦, À±È°Á¦ ¹× Èñ¼®Á¦, ¹æºÎÁ¦, ºÐÇØÁ¦, À¯È­Á¦ ¹× ±âŸ Ư¼ö ¿ëµµ°¡ Æ÷ÇԵ˴ϴÙ. ÀÌ Áß ÃæÀüÁ¦¿Í Èñ¼®Á¦´Â ƯÈ÷ Á¤Á¦ ¹× ĸ½¶°ú °°Àº °íÇü °æ±¸ Á¦ÇüÀÇ »ý»ê¿¡ Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. °æ±¸¿ë ÀǾàǰÀº Åõ¿©°¡ ½±°í ȯÀÚÀÇ ¼øÀÀµµ°¡ ³ô±â ¶§¹®¿¡ °¡Àå ¼±È£µÇ´Â Åõ¿© °æ·Î·Î ³²¾Æ ÀÖÀ¸¸ç, ÀÌ¿¡ µû¶ó ÀÌ·¯ÇÑ Ã·°¡Á¦ÀÇ Á߿伺Àº °è¼ÓÇØ¼­ Ä¿Áö°í ÀÖ½À´Ï´Ù. ÃæÀüÁ¦ ¹× Èñ¼®Á¦´Â ¼Ò·®ÀÇ È°¼º ÀÇ¾à ¼ººÐÀ» ÇÔÀ¯ÇÑ Á¦Çü¿¡ ºÎÇǸ¦ Á¦°øÇÏ¿© Á¤È®ÇÑ Åõ¿©·®°ú ÇÔ·® ±ÕÀϼºÀ» º¸ÀåÇÕ´Ï´Ù. Á¦Á¶ÀÇ °üÁ¡¿¡¼­, ÀÌ·¯ÇÑ Ã·°¡Á¦´Â Á¦ÇüÀÇ ¾ÈÁ¤¼º, °¡°øÀÇ ¿ëÀ̼º ¹× ´ë·® »ý»êÀÇ È®À强¿¡ Å©°Ô ±â¿©ÇÕ´Ï´Ù. ¶ÇÇÑ, È¥ÇÕ, Á¤Á¦, ĸ½¶È­ µîÀÇ °øÁ¤À» ´Ü¼øÈ­Çϸ鼭 Á¤Á¦ÀÇ ±â°èÀû °­µµ¸¦ Çâ»ó½Ãŵ´Ï´Ù. ȯÀÚÀÇ °æ¿ì, ÀÌ·¯ÇÑ ºÎÇüÁ¦´Â ¼Ò¾Æ ¹× ³ëÀÎ Àα¸¿¡°Ô Áß¿äÇÑ ¿ä¼ÒÀÎ ÀԾȿ¡¼­ÀÇ ´À³¦, ¸À ¹× Ãë±Þ¼ºÀ» °³¼±ÇÕ´Ï´Ù. ÀǾàǰ Á¦ÇüÀÌ Á¡Á¡ º¹ÀâÇØÁü¿¡ µû¶ó, Á¦¾î ¹æÃâ ¹× »ýü ÀÌ¿ë·ü Çâ»óÀ» Áö¿øÇÏ´Â °í¼º´ÉÀÇ ´Ù±â´É ÃæÀüÁ¦ ¹× Èñ¼®Á¦¿¡ ´ëÇÑ ¼ö¿äµµ Áõ°¡Çϰí ÀÖÀ¸¸ç, ÀÌ´Â ÀÌ ºÎÇüÁ¦ ºÎ¹®¿¡¼­ »ó´çÇÑ ¼ºÀå ±âȸ¸¦ Á¦½ÃÇϰí ÀÖ½À´Ï´Ù.

ÀǾàǰ ÷°¡Á¦ ½ÃÀåÀº Á¦Çü À¯Çü¿¡ µû¶ó °æ±¸ Á¦Çü, ±¹¼Ò Á¦Çü, ºñ°æ±¸ Á¦Çü ¹× ±âŸ Á¦ÇüÀ¸·Î ºÐ·ùµË´Ï´Ù. ÀÌ Áß °æ±¸ Á¦Çü ºÎ¹®Àº 2024³â¿¡ °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇϸç, °¡Àå ³Î¸® »ç¿ëµÇ°í ÀüÅëÀûÀÎ ¾à¹° Àü´Þ ¹æ¹ýÀ¸·Î¼­ÀÇ ¿ìÀ§¸¦ ¹Ý¿µÇß½À´Ï´Ù. °æ±¸ Åõ¿©´Â ÆíÀǼº, ºñ¿ë È¿À²¼º ¹× ³ôÀº ȯÀÚ ¼øÀÀµµ·Î ÀÎÇØ ȯÀÚ¿Í ÀÇ·á ¼­ºñ½º Á¦°øÀÚ¿¡°Ô ¼±È£µÇ´Â ¼±ÅÃÀÔ´Ï´Ù. ÀÌ ºÎ¹®Àº Á¤Á¦, ĸ½¶ ¹× ±âŸ °íÇü °æ±¸ Á¦Çü¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó °è¼Ó È®ÀåµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¹ÙÀÌ¿À ÀǾàǰ ¹× Á¦³×¸¯ ÀǾàǰ »ê¾÷ÀÇ ±Þ¼ÓÇÑ ¼ºÀåÀº °æ±¸ Á¦Ç°¿¡¼­ ÀǾàǰÀÇ ¾ÈÁ¤¼º, ¿ëÇØµµ ¹× »ýü ÀÌ¿ë·üÀ» Çâ»ó½ÃŰ´Â °íǰÁú ºÎÇüÁ¦¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇÏ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. Àå±âÀûÀÎ ¾à¹° Ä¡·á°¡ ÇÊ¿äÇÑ ¸¸¼º ÁúȯÀÇ À¯º´·ü Áõ°¡¿Í ÀǾàǰÀÇ ÀÚ°¡ Åõ¿© µ¿Çâµµ ÀÌ ºÎ¹®ÀÇ ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ±× °á°ú, Á¦¾à ȸ»ç´Â Çõ½ÅÀûÀÎ °æ±¸¿ë ÀǾàǰ Á¦Çü¿¡ ÅõÀÚÇϰí ÀÖÀ¸¸ç, ÀÌ·¯ÇÑ ¿ä±¸¿¡ ¸Â´Â ÷´Ü ºÎÇüÁ¦ÀÇ Çʿ伺ÀÌ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù.

¾Æ½Ã¾ÆÅÂÆò¾ç Áö¿ªÀÇ ÀǾàǰ ÷°¡Á¦ ½ÃÀåÀº ¿¹Ãø ±â°£ µ¿¾È ¸ðµç Áö¿ª Áß °¡Àå ³ôÀº CAGRÀ» ±â·ÏÇÏ¸ç °ßÁ¶ÇÑ ¼ºÀåÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿©·¯ °¡Áö »óÈ£ °ü·ÃµÈ ¿äÀεéÀÌ ÀÌ·¯ÇÑ ¼ºÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ÁÖ¿ä ÀåÁ¡ Áß Çϳª´Â ÀÌ Áö¿ªÀÇ ºñ¿ë È¿À²ÀûÀÎ Á¦Á¶ ´É·ÂÀ¸·Î, ÀÌ·Î ÀÎÇØ ÀÌ Áö¿ªÀº ÀǾàǰ »ý»ê ¹× ¾Æ¿ô¼Ò½Ì¿¡ ¸Å·ÂÀûÀÎ Çãºê·Î ÀÚ¸®¸Å±èÇß½À´Ï´Ù. Àεµ, Áß±¹, Çѱ¹°ú °°Àº ±¹°¡µéÀº dzºÎÇÑ ¿øÀÚÀç, ¼÷·ÃµÈ ³ëµ¿·Â, ÀǾàǰ R&D ¹× ¼öÃâ ÁöÇâÀû Á¦Á¶¸¦ Áö¿øÇÏ´Â À¯¸®ÇÑ Á¤ºÎ Á¤Ã¥À» Á¦°øÇÕ´Ï´Ù. ¶ÇÇÑ, ¾Æ½Ã¾ÆÅÂÆò¾ç Áö¿ªÀº ¼­±¸ ½ÃÀå¿¡ ºñÇØ »ó´ëÀûÀ¸·Î °ü´ëÇÑ ±ÔÁ¦ ü°è¸¦ °®Ãß°í ÀÖ¾î Á¦Ç° °³¹ß ¹× ½ÃÀå Ãâ½Ã ½Ã°£À» ´ÜÃàÇÒ ¼ö ÀÖ½À´Ï´Ù. 1ÀÎ´ç ¼ÒµæÀÇ ±Þ¼ÓÇÑ Áõ°¡, °Ç°­ ¹× À£ºù¿¡ ´ëÇÑ ÀνÄÀÇ Á¦°í, ÀÇ·áºñ ÁöÃâÀÇ Áõ°¡´Â Á¦³×¸¯ ÀǾàǰ¿¡ ´ëÇÑ ¼ö¿ä¸¦ ´õ¿í ºÎÃß±â°í ÀÖÀ¸¸ç, ÀÌ´Â ÀǾàǰ ÷°¡Á¦ ¼ö¿ä·Î±îÁö È®´ëµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, »ýȰ ½À°üº´ÀÇ ±ÞÁõ°ú °í·É Àα¸ÀÇ È®´ë´Â °æ±¸¿ë °íÇüÁ¦ ¹× ±¹¼Ò Á¦Á¦ µî Çõ½ÅÀûÀÎ ÀǾàǰ Á¦Çü¿¡ ´ëÇÑ ¼ö¿ä¸¦ Áõ°¡½Ã۰í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µ¿ÇâÀº Áö¿ª ¹× ¼¼°èÀÇ ºÎÇüÁ¦ Á¦Á¶¾÷üµéÀÌ »ç¾÷À» È®ÀåÇϰí, ÀÎÇÁ¶ó¿¡ ÅõÀÚÇϸç, Áõ°¡ÇÏ´Â Áö¿ª ¼ö¿ä¸¦ ÃæÁ·Çϱâ À§ÇØ Àü·«Àû ÆÄÆ®³Ê½ÊÀ» Çü¼ºÇÒ ¼ö ÀÖ´Â Áß¿äÇÑ ±âȸ¸¦ âÃâÇϰí ÀÖ½À´Ï´Ù.

º» º¸°í¼­¿¡¼­´Â ¼¼°èÀÇ ÀǾàǰ ÷°¡Á¦ ½ÃÀå¿¡ ´ëÇØ Á¶»çÇßÀ¸¸ç, Á¦Ç°º°, ±â´Éº°, Á¦Çüº°, ±â´É¼º ¿ëµµº°, Áö¿ªº° µ¿Çâ ¹× ½ÃÀå ÁøÃâ±â¾÷ ÇÁ·ÎÆÄÀÏ µîÀ» Á¤¸®Çß½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­·Ð

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå Áß¿ä ÀλçÀÌÆ®

Á¦5Àå ½ÃÀå °³¿ä

Á¦6Àå ÀǾàǰ ÷°¡Á¦ ½ÃÀå(Á¦Ç°º°)

Á¦7Àå ÀǾàǰ ÷°¡Á¦ ½ÃÀå(±â´Éº°)

Á¦8Àå ÀǾàǰ ÷°¡Á¦ ½ÃÀå(Á¦Çüº°)

Á¦9Àå ÀǾàǰ ÷°¡Á¦ ½ÃÀå(±â´É¼º ¿ëµµº°)

Á¦10Àå ÀǾàǰ ÷°¡Á¦ ½ÃÀå(Áö¿ªº°)

Á¦11Àå °æÀï ±¸µµ

Á¦12Àå ±â¾÷ ÇÁ·ÎÆÄÀÏ

Á¦13Àå ºÎ·Ï

HBR
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The global pharmaceutical excipients market is projected to reach USD 14.86 billion by 2030 from USD 11.03 billion in 2025, at a CAGR of 6.1% during the forecast period.

Scope of the Report
Years Considered for the Study2023-2030
Base Year2024
Forecast Period2025-2030
Units ConsideredValue (USD billion)
SegmentsBy Product, Functionality, Formulation, Functionality, and Application
Regions coveredNorth America, Europe, Asia Pacific, Latin America, the Middle East, and Africa

The expansion of the Pharmaceutical Excipients market has been predominantly driven by the Surging demand for pharmaceutical products and generic medicines, and R&D investments for novel excipient development are predicted to uplift the market in the coming years. Additionally, partnerships and collaboration with pharmaceutical companies and increased emphasis on patient-centric formulations will provide lucrative market growth opportunities. However, regulatory stringency and steep development costs are predicted to restrict the market.

Pharmaceutical Excipients Market - IMG1

The fillers & diluents functionality held the highest share in the pharmaceutical excipients market.

The pharmaceutical excipients market, segmented by functionality, includes binders, suspending and viscosity agents, fillers and diluents, flavoring agents and sweeteners, colorants, coating agents, lubricants and glidants, preservatives, disintegrants, emulsifying agents, and other specialized roles. Among these, fillers and diluents play a critical role, especially in the production of solid oral dosage forms like tablets and capsules. Their importance continues to grow with the rising demand for oral medications, which remain the most preferred route due to ease of administration and patient compliance. Fillers and diluents provide bulk to formulations containing small amounts of active pharmaceutical ingredients and help ensure accurate dosage and improved content uniformity. From a manufacturing perspective, they contribute significantly to formulation stability, ease of processing, and scalability in mass production. They simplify processes such as blending, tableting, and encapsulation while enhancing the mechanical strength of tablets. For patients, these excipients improve mouthfeel, taste, and handling, which are crucial factors for pediatric and geriatric populations. As drug formulations become more complex, the demand for high-performance, multifunctional fillers and diluents that support controlled release and bioavailability enhancement is also rising, presenting significant growth opportunities in this excipient category.

The oral formulations segment reported the highest share of the formulations segment in 2024.

The pharmaceutical excipients market is categorized based on formulation types into oral formulations, topical formulations, parenteral formulations, and other formulations. Among these, the oral formulations segment held the largest market share in 2024, reflecting its dominance as the most widely used and traditional drug delivery method. The convenience, cost-effectiveness, and high patient compliance associated with oral administration make it a preferred choice for patients and healthcare providers. This segment continues to expand due to the rising demand for tablets, capsules, and other solid oral dosage forms. Furthermore, the rapid growth of the biopharmaceutical and generics industries is playing a pivotal role in driving demand for high-quality excipients that enhance drug stability, solubility, and bioavailability in oral products. The increasing prevalence of chronic conditions requiring long-term medication and the trend toward self-administration of drugs also contribute to the growth of this segment. As a result, pharmaceutical companies are investing in innovative oral drug formulations, boosting the need for advanced excipients tailored to these needs.

Asia Pacific is expected to grow at the highest CAGR in the global pharmaceutical excipients market from 2025 to 2030.

The pharmaceutical excipients market in the Asia Pacific region is expected to grow robustly and register the highest CAGR among all regions during the forecast period. Several interrelated factors are driving this expansion. One of the key advantages is the region's cost-effective manufacturing capabilities, which make it an attractive hub for pharmaceutical production and outsourcing. Countries like India, China, and South Korea offer abundant raw material availability, skilled labor, and favorable government policies that support pharmaceutical R&D and export-oriented manufacturing. Additionally, the Asia Pacific region has relatively lenient regulatory frameworks compared to Western markets, which accelerates product development and time-to-market. The rapid rise in per capita income, growing awareness of health and wellness, and increased healthcare spending are further fueling demand for generic drugs and, by extension, pharmaceutical excipients. Moreover, a surge in lifestyle-related chronic diseases and expanding geriatric populations have led to greater demand for innovative drug formulations, including oral solids and topical applications. These trends create significant opportunities for local and global excipient manufacturers to expand operations, invest in infrastructure, and form strategic partnerships to meet the growing regional demand.

The primary interviews conducted for this report can be categorized as follows:

List of Key Companies Profiled in the Report

Key players in the pharmaceutical excipients market include International Flavors & Fragrances Inc. (US), Ashland Inc. (US), Evonik Industries AG (Germany), BASF SE (Germany), Kerry Group plc (Ireland), Roquette Freres (France), MERCK KGaA (Germany), Associated British Foods plc (UK), ADM (US), Wacker Chemie AG (Germany), Air Liquide (France), DOW (US), Berkshire Hathaway Inc. (US), Colorcon (US), DFE PHARMA (Germany), Actylis (US), Croda International Plc(UK), Chemie Trade(India), Gattefosse (France), JRS Pharma(US), and Shin-Etsu Chemical Co., Ltd. (Japan).

Research Coverage

This research report categorizes the pharmaceutical excipients market by Product [(Organic (Oleochemicals, Carbohydrates, Petrochemicals, Proteins, and Other Organic Chemicals), Inorganic (Calcium Phosphate, Metal Oxides, Halites, Calcium Carbonate, Calcium Sulfate, Other Inorganic Chemicals), Other chemicals], by Functionality (Fillers & Diluents, Suspending & Viscosity Agents, Coating Agents, Binders, Flavoring Agents & Sweeteners, Disintegrants, Colorants, Lubricants & Glidants, Preservatives, Emulsifying Agents, and Other Functionalities), by formulation (Oral (Tablets, Capsules, Liquid Formulations and other oral formulations), Topical Formulations, Parenteral Formulations, and Other Formulations), by Functionality Application (Stabilizers, Taste Making, Modified Release, Solubility & Bioavailability Enhancement and Other Functionality Applications), and by Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa).

The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the pharmaceutical excipients market. A detailed analysis of the key industry players has been done to provide insights into their business overview, products, solutions, key strategies, collaborations, partnerships, and agreements. New approvals/launches, collaborations, acquisitions, and recent developments associated with the pharmaceutical excipients market.

Reasons to Buy this Report

The report will help market leaders and new entrants by providing them with the closest approximations of the revenue numbers for the overall pharmaceutical excipients market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their businesses and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.

The report provides insights on the following pointers:

TABLE OF CONTENTS

1 INTRODUCTION

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

5 MARKET OVERVIEW

6 PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT

7 PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY

8 PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION

9 PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION

10 PHARMACEUTICAL EXCIPIENTS MARKET, BY REGION

11 COMPETITIVE LANDSCAPE

12 COMPANY PROFILES

13 APPENDIX

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â